Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...

A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...

Retired tennis star Monica Seles recently announced her diagnosis of myasthenia gravis (MG), a neuromuscular autoimmune disease. MG causes muscle weakness and fatigue, and while incurable, it affects ...

Monica Seles, winner of nine Grand Slam titles and a member of the International Tennis Hall of Fame, has spoken publicly for the first time about being diagnosed with myasthenia gravis. She received ...

Nine-time Grand Slam champion Monica Seles is speaking out about her health for the first time after she was diagnosed three years ago with a rare neuromuscular autoimmune disease. The International ...

Monica Seles first noticed the symptoms of myasthenia gravis — a neuromuscular autoimmune disease she discussed during a recent interview with The Associated Press — while she was swinging a racket ...

Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older with generalized myasthenia gravis based on data from the ongoing ...

Nicholas J. Silvestri, MD, expects that the upcoming 2025 American Academy of Neurology Annual Meeting in San Diego will be an exciting event for the field of myasthenia gravis (MG), with anticipated ...

The FDA has approved the CD19+ B-cell targeted therapy inebilizumab-cdon (Uplizna, Amgen) for the treatment of adults with generalized myasthenia gravis (gMG) who test positive for anti-acetylcholine ...

New compelling results demonstrate 18 months of both sustained reduction in immunoglobulin G antibodies and sustained improvement in gMG symptoms in pivotal Vivacity-MG3 study and open-label extension ...